Repozytorium UR

Neoadjuvant therapy in breast cancer – objectives and tasks

DSpace Repository

Show simple item record

dc.contributor.author Ostańska, Elżbieta
dc.contributor.author Bartusik-Aebisher, Dorota
dc.contributor.author Aebisher, David
dc.contributor.author Kaznowska, Ewa
dc.date.accessioned 2019-07-16T07:16:16Z
dc.date.available 2019-07-16T07:16:16Z
dc.date.issued 2019
dc.identifier.citation European Journal of Clinical and Experimental Medicine T. 17, z. 2 (2019), s. 153–156 pl_PL.UTF-8
dc.identifier.issn 2544-2406
dc.identifier.uri http://repozytorium.ur.edu.pl/handle/item/4759
dc.description Dorota Bartusik-Aebisher acknowledges support from the National Center of Science NCN (New drug delivery systems-MRI study, Grant OPUS-13 number 2017/25/B/ST4/02481). pl_PL.UTF-8
dc.description.abstract Introduction. Neoadiuvant therapy (NCT) in the treatment of breast cancer is employed for patients with early stage disease or with inoperable disease. NCT can decrease the tumor volume. It can facilitate breast conservation therapy. Response to NCT is a strong predictor of outcome breast cancer (BC). Direct target therapies has markedly improved the result of treatment BC. Aim. Therapy for breast cancer continues to improve. The importance of tumor burden on local control rates will be in the future. Material and methods. This analysis was performed using a systematic literature search. Results. The latest scientific reports give hope for greater safety and a better life for patients based on optimized and effective therapy. Conclusion. Currently, improving the effectiveness of breast cancer treatment is mainly related to the optimal use of classic therapeutic strategies. New classes of substances have been approved for treatment or are in advanced stages of clinical development. pl_PL.UTF-8
dc.language.iso eng pl_PL.UTF-8
dc.publisher Wydawnictwo Uniwersytetu Rzeszowskiego pl_PL.UTF-8
dc.rights Attribution-NonCommercial-NoDerivatives 4.0 Międzynarodowe *
dc.rights.uri http://creativecommons.org/licenses/by-nc-nd/4.0/ *
dc.subject neoadjuvant therapy (NCT) pl_PL.UTF-8
dc.subject breast cancer (BC) pl_PL.UTF-8
dc.subject triple negative breast cancer (TNBC) pl_PL.UTF-8
dc.title Neoadjuvant therapy in breast cancer – objectives and tasks pl_PL.UTF-8
dc.type review pl_PL.UTF-8
dc.identifier.doi 10.15584/ejcem.2019.2.8
dc.identifier.eissn 2544-1361


Files in this item

The following license files are associated with this item:

This item appears in the following Collection(s)

Show simple item record

Attribution-NonCommercial-NoDerivatives 4.0 Międzynarodowe Except where otherwise noted, this item's license is described as Attribution-NonCommercial-NoDerivatives 4.0 Międzynarodowe

Search DSpace


Browse

My Account

Statistics

Informacje